Picture of Kamada logo

KMDA Kamada Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Annual income statement for Kamada, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARS20-F20-F20-F20-F
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue104129143161180
Cost of Revenue
Gross Profit30.346.755.57076.4
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses104125132141154
Operating Profit-0.6964.5310.120.126.2
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-1.89-2.268.4313.323.5
Provision for Income Taxes
Net Income After Taxes-2.23-2.328.2814.520.2
Net Income Before Extraordinary Items
Net Income-2.23-2.328.2814.520.2
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-2.23-2.328.2814.520.2
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.05-0.0520.1540.250.346
Dividends per Share